David Hirsh
Chairman at New York Structural Biology Center, Inc.
Profile
David I.
Hirsh currently works at New York Structural Biology Center, Inc., as Chairman, Cellphire, Inc., as Director, Visum Pharma, Inc., as Director, Warburg Pincus LLC, as Advisory Board, The Trustees of Columbia University in The City of New York, as Executive Vice President-Research from 2003, and Accelerator Services Corp, as Advisory Board.
Dr. Hirsh also formerly worked at ZymoGenetics, Inc., as Director from 2000 to 2010, Synergen, Inc., as Executive Vice President-Research from 1984 to 1990, and The University of Colorado, as Professor from 1971 to 1985.
Dr. Hirsh received his undergraduate degree from The Reed Institute and doctorate degree from The Rockefeller University.
David Hirsh active positions
| Companies | Position | Start |
|---|---|---|
| The Trustees of Columbia University in The City of New York | Chief Tech/Sci/R&D Officer | 31/08/2003 |
New York Structural Biology Center, Inc.
 New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Chairman | - |
Cellphire, Inc.
 Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Director/Board Member | - |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Consultant / Advisor | - |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | - |
Visum Pharma, Inc.
 Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Visum Pharma, Inc. provides therapeutics for neurodegenerative diseases. The company is based in Stamford, CT. The CEO of the company is William J. Gedale. | Director/Board Member | - |
Former positions of David Hirsh
| Companies | Position | End |
|---|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Director/Board Member | 07/10/2010 |
| Synergen, Inc. | Chief Tech/Sci/R&D Officer | 31/12/1989 |
| The University of Colorado | Corporate Officer/Principal | 31/12/1984 |
Training of David Hirsh
| The Reed Institute | Undergraduate Degree |
| The Rockefeller University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
| Synergen, Inc. | Utilities |
New York Structural Biology Center, Inc.
New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Health Technology |
Cellphire, Inc.
Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Health Technology |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Finance |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Visum Pharma, Inc.
Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Visum Pharma, Inc. provides therapeutics for neurodegenerative diseases. The company is based in Stamford, CT. The CEO of the company is William J. Gedale. | Health Technology |
- Stock Market
- Insiders
- David Hirsh
